ESC & iPSC News 14.30 August 7, 2019 | |
| |
TOP STORYScientists used genome edited human ESCs to understand the most common form of monogenic diabetes, MODY3, caused by mutations in the transcription factor HNF1A. [Cell Stem Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers generated human iPSCs with controllable expression of SIRT1. By differentiating edited iPSCs into hepatocytes and knocking down SIRT1, they found increased fatty acid biosynthesis that exacerbated fat accumulation. [Cell Metab] Abstract | Graphical Abstract The authors found that initial silencing of the somatic program proceeded indistinguishably with or without Oct4. Oct6 mitigated the mesenchymal-to-epithelial transition and derailed reprogramming. [Nat Commun] Full Article Investigators determined that Cited2 depletion in ESCs affected the expression of transcription factors and cardiopoietic genes involved in early mesoderm and cardiac specification. [Cell Death Dis] Full Article Healthy control individuals as well as patients with schizophrenia and autism spectrum disorder were examined by a panel of diagnostic tests. Subsequently, skin biopsies were taken for the generation, differentiation, and testing of human iPSC-derived neurons from all individuals. [Transl Psychiatry] Full Article Scientists investigated the response of LQT2-iPSC-derived cardiomyocytes (iPSC-CMs) following IKr blockade using a multi-electrode array, finding that the response to IKr blockade was significantly smaller than in Control-iPSC-CMs. [Stem Cell Reports] Full Article iPSCs were generated from peripheral blood mononuclear cells isolated from the peripheral blood of a four month-old boy with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations RyR2-A1855D and SCN10A-Q1362H. [Stem Cell Res] Abstract The authors showed that the transient inhibition of the FGF/MAPK signaling pathway during the hiPSC maintenance period markedly promoted retinal pigment epithelium differentiation efficiency under feeder-free culture conditions. [Stem Cell Res] Full Article MicroRNA Profiling During Neural Differentiation of Induced Pluripotent Stem Cells Researchers confirmed the new associations of previously described miRNAs in regulation of neuronal stem cell differentiation from iPSCs. They discovered upregulation of miR-10 family, miR-30 family and miR-9 family, and downregulation of miR-302 and miR-515 family expression. [Int J Mol Sci] Full Article Human Circadian Molecular Oscillation Development Using Induced Pluripotent Stem Cells Scientists showed that human iPSCs had no discernible circadian molecular oscillation. In addition, in vitro differentiation culture of human iPSCs required a longer duration than that required in mouse for the emergence of circadian oscillations. [J Biol Rhythms] Full Article Subscribe to one of our other 19 science newsletters such as Cell Therapy News & Mesenchymal Cell News. | |
| |
REVIEWSModeling Alzheimer’s Disease with iPSC-Derived Brain Cells Many cellular functions perturbed in Alzheimer’s disease can be recapitulated using iPSC-derived cells in vitro, and co-culture platforms are beginning to yield insights into the complex interactions that occur between brain cell types during neurodegeneration. [Mol Psychiatry] Full Article Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells The authors focus on the large animal models of pigs, dogs, horses and sheep/goats, and summarize current progress, challenges, and potential future directions of research on large animal iPSCs. [Stem Cells Dev] Abstract Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSCIRM Board Approves $19.7 Million in Awards for Translational Research Program In addition to approving funding for breast cancer related brain metastases, the CIRM Board also approved an additional $19.7 million geared towards their translational research program. [CIRM] Press Release Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates Rewind Therapeutics announced it will lead a new industry-academic R&D collaboration to discover and develop first-in-class inhibitors of a key G protein-coupled receptor target that has an influential role in myelin-related neurological diseases. [Rewind Therapeutics] Press Release | |
| |
POLICY NEWSResearchers Weigh in on Trump’s $500 Million Plan to Share Childhood Cancer Data The Childhood Cancer Data Initiative, as the National Cancer Institute (NCI) has dubbed it, could have many payoffs, such as devising less harsh treatments and figuring out why 10% of childhood leukemia patients don’t respond to treatments or relapse, said NCI acting director Doug Lowy. And for very rare cancers with no treatments, pooling such data on cases is essential for researchers to draw firm conclusions. [ScienceInsider] Editorial First Human-Monkey Chimeras Developed in China Juan Carlos Izpisúa Belmonte of the Salk Institute in San Diego is spearheading the project with scientists from his own lab and those from the Murcia Catholic University in Murcia, Spain. The team wants to develop chimeras—organisms composed of cells from two or more species—capable of growing human organs. [The Scientist] Editorial The Public’s Trust in Scientists Rises, Pew Poll Shows Public trust in science rose in recent years, a new survey shows: 86 percent of Americans say that they have at least “a fair amount” of confidence in scientists to act in the public interest, up from 78 percent in 2016. [The Scientist] Editorial
| |
EVENTSNEW 8th Annual International Symposium on Regenerative Rehabilitation Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Anatomy and Embryology (Leiden University Medical Center) NEW Biologist – Stem Cell Engineering (National Institute of Neurological Disorders and Stroke) Scientific Communications Coordinator (STEMCELL Technologies Inc.) Research Technologist – Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.) Postdoctoral Associate – Cancer and Glioma Stem Cell Biology (Weill Cornell Medicine) Postdoctoral Fellow Positions – Cancer Research (Nationwide Children’s Hospital) Research Technician – Beta Cell Production from Human PSCs (Helmholtz Zentrum München) Senior Scientist – Cell Engineering and Characterization (Merck & Co., Inc) Associate Professor – Developmental and Stem Cell Biology (The University of Hong Kong) Postdoctoral Fellows – Striated Muscle Regeneration (Duke University) Postdoctoral Fellow – Pluripotent Stem Cells & Joint Tissue Development (Boston Children’s Hospital) Postdoctoral Fellow – Genetics and Epigenomics of iPSC Biology (Stanford University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|